1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Calm before the storm: understanding the role of JAK inhibitors in COVID-19

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Contributors
          Journal
          J Am Acad Dermatol
          J. Am. Acad. Dermatol
          Journal of the American Academy of Dermatology
          by the American Academy of Dermatology, Inc.
          0190-9622
          1097-6787
          25 April 2020
          25 April 2020
          Affiliations
          [1 ]Department of Dermatology, Yale School of Medicine, 333 Cedar St, LCI 501, PO Box 208059, New Haven, Connecticut, USA, 06510
          Author notes
          [] Corresponding authors: William Damsky, MD, PhD 333 Cedar St, LCI 501 PO Box 208059 New Haven CT 06510 william.damsky@ 123456yale.edu
          [∗∗ ] Corresponding authors: Brett King, MD, PhD, 333 Cedar St, LCI 501, PO Box 208059, New Haven CT 06510, brett.king@ 123456yale.edu
          Article
          S0190-9622(20)30713-1
          10.1016/j.jaad.2020.04.097
          7194643
          32344070
          94aea72f-d15b-4e17-996f-86c8cd7ee345
          © 2020 by the American Academy of Dermatology, Inc.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 20 April 2020
          : 21 April 2020
          Categories
          Article

          sars-cov-2,covid-19,coronavirus,janus kinase inhibitors,jak,immunosuppressants,immunomodulators,autoimmune disease,general dermatology,medical dermatology

          Comments

          Comment on this article